
M-tron Industries, Inc. (MPTI)
M-tron Industries, Inc. (MPTI) is a manufacturer specializing in engineered electronic and electro-mechanical components, including connectors, switches, and instrumentation products. The company serves various markets such as medical, industrial, aerospace, and military, providing custom and standard solutions to meet diverse customer needs.
Company News
M-tron Industries reported Q2 2025 earnings with 12.5% revenue growth but missed EPS expectations due to margin compression from tariffs and higher operating costs. The company maintains a strong backlog and continues to focus on high-reliability markets like aerospace and defense.
M-tron Industries, Inc. (MPTI) stock saw a 0.55% decline in the latest trading session, underperforming the broader market. Analysts and investors will be closely watching the company's upcoming earnings report, which is expected to show year-over-year growth.
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. DICE Therapeutics, Inc. (NASDAQ: DICE) shares gained 62.3% to close at $40.00 after the company announced topline data from its Phase 1 clinical trial of DC-806. Clinical proof-of-concept in psoriasis patients achieved with a mean percentage reduction in PASI from baseline at 4 weeks of 43.7% in the high dose group. Immunic, Inc. (NASDAQ: IMUX) surged 51.8% to close at $9.41. Immunic recently announced $60 million oversubscribed private placement equity financing. ForgeRock, Inc. (NYSE: FORG) rose 48.6% to close at $22.52 after the company announced it will be acquired by Thoma Bravo for $2.3 billion. Laser Photonics Corporation (NASDAQ: LASE) gained 44.4% to close at $2.70 after the company announced it received an order from the U.S. Navy for delivery this month of an LPC-1000CTH CleanTech Laser Blasting System with an integrated water chiller for submarine MRO. scPharmaceuticals Inc. (NASDAQ: SCPH) gained 39.3% to close at $5.60. SVB Leerink upgraded scPharmaceuticals from Market Perform to Outperform and raised the price target from $6 to $11. Oblong, Inc. (NASDAQ: OBLG) rose 38.6% to close at $0.2340. AMTD Digital Inc. (NYSE: HKD) gained 35.3% to settle at $41.15. Meiwu Technology Company Limited (NASDAQ: WNW) climbed 33.7% to close at $1.17. Agrify Corporation (NASDAQ: AGFY) gained 32.6% to close at $0.5074. Mercurity Fintech Holding Inc. (NASDAQ: MFH) surged 30.8% to close at $1.06. Bright Health Group, Inc. (NYSE: BHG) gained 28.6% to close at $1.17. NantHealth, Inc. (NASDAQ: NH) surged 22.9% to close at $0.2899. Lottery.com Inc. (NASDAQ: LTRY) climbed 21.3% to close at $0.3021. Innovative Eyewear, Inc. (NASDAQ: LUCY) gained 20.4% to close at $2.60. Minerva Neurosciences, Inc. (NASDAQ: NERV) rose 19% to settle at $12.46. Braskem S.A. (NYSE: BAK) shares climbed 18.8% to close at $12.76 following a report suggesting Apollo has made a new offer for the company. Mawson Infrastructure Group, Inc. (NASDAQ: MIGI) gained 18% to close at $0.5538. Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) rose 16.4% to close at $0.1464. Adamis Pharmaceuticals recently initiated a process to explore a range of strategic and financing alternatives. Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) gained 16.3% to close at $3.22. Greenbrook TMS Inc. (NASDAQ: GBNH) climbed 14.9% to close at $3.32. Albireo Pharma, Inc. (NASDAQ: ALBO) shares gained 14.4% to close at $23.42 after the company announced topline results from the Phase 3 of Bylvay in Alagille syndrome showed highly statistically significant improvement in pruritus primary endpoint. Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) rose 14.3% to close at $8.00. UBS initiated coverage on Rani Therapeutics with a ...